Live Chat ×
Skip to main content

Pediatric State of the Art Symposium 2014

Recorded December 2014

Overview

Seizures occur in a significant number of neonates, yet many critical questions remain regarding their diagnosis, treatment, and long-term prognosis. Modern neurophysiological monitoring indicates that the scope of the neonatal seizure problem may be more extensive than previously appreciated. Although contemporary neuroprotective strategies have led to improved short-term outcomes, the impact of both seizures and the medications used to treat them are now being explored more rigorously in both animal models and humans. There is a need for clinicians who treat infants, children, adolescents, and even adults to become familiar with the long-term sequelae of neonatal seizures. Importantly, these sequelae include not only seizures — cognitive, neuropsychological and social outcomes are affected, as well. This State of the Art Symposium will address the long-term outcomes of neonatal seizures, with a focus on both epilepsy and non-epilepsy factors.

Learning Objectives

  • Recognize long-term sequelae of neonatal seizures from information provided by outcome studies
  • Choose appropriate medications used to treat neonatal seizures based on information from follow up studies regarding long-term sequelae
  • Utilizing information provided regarding long-term sequelae of neonatal seizures and medications used to treat them, counsel families about seizure- and development related outcomes after neonatal seizures.
Target Audience
Intermediate and Advanced

Program
Co-Chairs: Adam Hartman, M.D. and Renée A. Shellhaas, M.D., M.S.Introduction and Case Presentation
Adam Hartman, M.D.
Introduction to Neonatal Seizures
Geraldine Boylan, Ph.D.
Clinical and EEG Predictors of Prognosis
Renée A. Shellhaas, M.D., M.S.
Are Neonatal Seizures So Bad?
Rodney Scott, M.D.
Are Seizure Medicines So Bad?
Timothy Benke, M.D., Ph.D.
Neonatal Seizure Management 2014
Janet Soul, M.D.
Conclusions
Renée A. Shellhaas, M.D., M.S.